Key clinical point: Treatment at a minority-serving hospital was not associated with higher risk of death among patients undergoing surgery for hepatocellular carcinoma.
Major finding: The multivariable hazard ratio for death was 0.89 (95% confidence interval, 0.72-1.11).
Study details: Analysis of National Cancer Database for 2004-2014. All patients who underwent surgical resection for hepatocellular carcinoma were included.
Disclosures: Dr. Mehtsun reported having no relevant conflicts of interest.
Mehtsun WT et al. DDW 2020, Abstract Tu2043.